Skip to content
CancerIndex

Publication

RET-driven osteoprotegerin expression links medullary thyroid cancer to osteoblastic bone metastases.

Rozita Bagheri-Yarmand, Gabriel M Pagnotti, Joseph L Kidd, David Avila Ramirez, Trupti Trivedi, Leah Guerra, Zhongya Wang, Lucia Martinez Cruz, Jade M Moehle, Yaashmin S Jebaraj, Xinhai Wan, Jian H Song, Roland L Bassett, Sue-Hwa Lin, Mimi I Hu, Steven I Sherman, Marie-Claude Hofmann, Theresa A Guise

Cell reports. MedicineSep 15, 2026PMID 42660113doi:10.1016/j.xcrm.2026.103010 PMC13589480Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 26, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260926-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Development of bone metastases increases mortality in patients with medullary thyroid cancer (MTC), with ∼50% survival at 5 years after diagnosis, but the underlying mechanisms of action are unknown. We show that patient-derived MTC cells (RETC634W mutant TT and RETM918T mutant MZCRC1 cells)…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.